Novartis will seek regulatory approval for 'smart pill'
Not at the mHealth Summit either: Novartis expects within 18 months to go for regulatory approval–probably European first–of the Proteus Biomedical chip-implanted ‘smart pill’. Trevor Mundel, Novartis global head of development, announced at the Reuters Health Summit in New York… Read moreNovartis will seek regulatory approval for 'smart pill'